Clinical trial
Multi-Center Phase 3 Trial of Chlorhexidine Gluconate Chip for the Use in Subjects With Peri-Implantitis.
NCT02080403 is registered in ClinicalTrials.gov with Dexcel Pharma Technologies Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Multi-Center Phase 3 Trial of Chlorhexidine Gluconate Chip for the Use in Subjects With Peri-Implantitis.
- Lead sponsor
- Dexcel Pharma Technologies Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- July 31, 2014
- Completion date
- November 30, 2018
- Enrollment
- 290 (actual)
- Sites
- 10
Conditions
As the registry lists them; a condition with its own page is linked.